{{Rsnum
|rsid=80338746
|Chromosome=2
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LRP2
|position=169247447
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=LRP2
}}{{omim
|id=600073
|rsnum=80338746
|variant=0003
}}{{ClinVar
|rsid=80338746
|Reversed=1
|FwdREF=A
|FwdALT=G
|REF=T
|ALT=C
|RSPOS=170103957
|CHROM=2
|dbSNPBuildID=131
|SSR=0
|SAO=0
|VP=050368000a05000002110100
|GENEINFO=LRP2:4036
|GENE_NAME=LRP2
|GENE_ID=4036
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000002.11:g.170103957T>C
|CLNSRC=OMIM Allelic Variant; GeneReviews
|CLNORIGIN=0
|CLNSRCID=600073.0003; NBK1878
|CLNSIG=5
|CLNCUI=C1857277; C1857277
|CLNDBN=Donnai Barrow syndrome
|Disease=Donnai Barrow syndrome
|CLNACC=SCV000030281.1; SCV000041097.1
|Tags=RV;PM;PMC;S3D;SLO;NSM;REF;ASP;OTHERKG;LSD;OM
}}{{PMID|12923867}} Donnai-Barrow syndrome: four additional patients.

{{PMID|17632512|OA=1
}} Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes.